12-Jun-2006 - Pall is organising a free chromatography seminar in Paris this week presented by leading chromatographers from the pharmaceutical, biotechnology and biologicals industries.
08-Jun-2006 - Werum Software & Systems has updated its manufacturing execution systems (MES) for the pharmaceutical and biopharmaceutical industry, enhancing process reliability and cost effectiveness.
06-Jun-2006 - German biopharma firm Sandoz has won a landmark first-of its-kind biosimilar drug approval in the US after a long battle with the US Food and Drug Administration (FDA). The decision could open the floodgates for generics manufacturers in this lucrative market.
06-Jun-2006 - Major drug companies across the US are in process of reformulating their over-the-counter cold medications in time for a new law that comes in to effect later this year restricting the sale of drugs that contain pseudoephedrine.
05-Jun-2006 - As demand for protein-based drugs increases, Pall has introduced a new type of mixed-mode chromatography sorbents that make protein purification faster and cheaper.
05-Jun-2006 - A new e-learning course promises to cover everything one needs to know about demanding current good manufacturing practice (cGMP) topics such as standard operating procedures (SOPs).
01-Jun-2006 - MAP Pharmaceuticals has awarded the manufacturing of the metered-dose components of its new inhaler devices to Xemplar, who is one of the few contract manufacturers in the world that can take on such a challenge and is now upping manufacturing capacity to meet future demand in this evolving market.
01-Jun-2006 - Pro Mach, one of the largest providers of packaging products, services and integrated solution sets in North America, has acquired Allpax Products, a manufacturer of sterilisation, material handling and automated control systems for the food, beverage and pharmaceutical industries.
01-Jun-2006 - RSSL Pharma Training has established three new courses to help UK pharmaceutical and medical device manufacturers prepare themselves for a plant inspection by the US Food and Drug Administration (FDA).
31-May-2006 - The University of Kentucky has unveiled the state's largest sterile pharmaceutical manufacturing site which is unique among others worldwide as it is the first to produce cytotoxic and non-cytotoxic drugs in the same room at the same time.
30-May-2006 - MFIC Corporation, whose Microfluidics Division manufactures industrial submicron processing equipment, has returned to profitability in the first quarter of 2006 after big losses in first quarter of last year, buoyed by increased demand from drugmakers who are scaling up their production for clinical trials and commercialisation.
30-May-2006 - India's Dishman Pharmaceuticals & Chemicals has snapped up the Swiss-based pharmaceutical services business, Carbogen and Amcis, of financially-troubled US chemical firm Solutia for the sum of $74.5m (€58m).
25-May-2006 - Phosphagenics is constructing a new tocopheryl phosphates manufacturing plant in Melbourne, Australia - a project that paves the way for future licensing agreements and could encourage the use of its technology in more of the company's pharmaceutical products.
24-May-2006 - The European Medicines Agency (EMEA) has given Sanofi Pasteur the green light to market a childhood vaccine containing Delta's Recombumin, a recombinant human albumin which offers the world's first and only animal-free alternative to human serum albumin (HSA).
23-May-2006 - Lonza has been authorised by the US Food and Drug Administration (FDA) to produce Bristol-Myers Squibb's arthritis drug Orencia (abatacept), in what is shaping up to be a major manufacturing deal for the Swiss company.
23-May-2006 - German biopharmaceutical company Boehringer Ingelheim has clinched a licencing deal for XstalBio's formulation and stabilisation technology which can be applied to the delivery of biomolecules via a number of routes, including pulmonary, as well as the preparation of high concentration suspensions.
23-May-2006 - Vandalia Research has launched a new DNA amplification service that it claims will speed up the mass production of high-quality DNA sequences with the polymerase chain reaction (PCR), while at the same time reducing the risk of contamination.
22-May-2006 - Contract biomanufacturing firm Laureate has won a contract to produce Seattle Genetics' humanised monoclonal antibody product candidates for clinical trial, adding to its experience in monoclonal antibody development.
22-May-2006 - Biopharmaceutical firm Oragenics has received funding from a US government agency for a technology which promises cost-effective production of commercially important bioactive peptides with unusual structures.
18-May-2006 - Cardinal Health has taken the contract manufacturing crown after being honoured with a prestigious award from Frost & Sullivan in recognition of its ability to provide biopharma firms with a high quality service, while still remaining extremely competitively priced.
18-May-2006 - Scientists seeking new ways to produce Roche's flu drug Tamiflu (oseltamivir) have published two new syntheses based on cheaper starting materials than the conventional method.
17-May-2006 - Genentech has entered into a collaboration with biopharmaceutical firm Immunogen to develop a commercial manufacturing process for its anticancer drug trastuzumab (Herceptin) using its tumour-activated prodrug (TAP) technology.
17-May-2006 - Registration is now open for this year's International Society for Pharmaceutical Engineering (ISPE) European Congress. The topic of focus is science-based manufacturing for the next decade.
17-May-2006 - UK firm Avecia Biotechnology has been given a £1m (€1.5m) grant to lead a three year project to establish a faster and cheaper bioprocessing technology for advanced tissue engineering, primarily to develop new skin to heal burns victims.
16-May-2006 - Looking to make protein-based drugs faster and cheaper, Merck & Co has acquired biotechnology company GlycoFi for approximately $400m (€312m) in cash.